DrugPatentWatch Database Preview
Competitive Generic Therapies: Off-Patent Drugs With 2 Sources
» See Plans and Pricing
This table lists drugs which, despite having no patents or regulatory protections, have a limited number of active sources.
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Strength |
|---|---|---|---|---|---|---|---|---|---|---|
| Lupin Ltd | ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE | abacavir sulfate; lamivudine; zidovudine | TABLET;ORAL | 202912-001 | Dec 5, 2013 | AB | RX | No | No | EQ 300MG BASE;150MG;300MG |
| Viiv Hlthcare | TRIZIVIR | abacavir sulfate; lamivudine; zidovudine | TABLET;ORAL | 021205-001 | Nov 14, 2000 | AB | RX | Yes | Yes | EQ 300MG BASE;150MG;300MG |
| Perrigo | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | acetaminophen; aspirin; caffeine | TABLET;ORAL | 075794-001 | Nov 26, 2001 | OTC | No | No | 250MG;250MG;65MG | |
| Glaxosmithkline Cons | EXCEDRIN (MIGRAINE) | acetaminophen; aspirin; caffeine | TABLET;ORAL | 020802-001 | Jan 14, 1998 | OTC | Yes | Yes | 250MG;250MG;65MG | |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Strength |
